1. Introduction {#sec1}
===============

Major Depressive Disorder (MDD) constitutes the second leading cause of disability worldwide and is associated with a substantial socio-economic burden ([@bib53; @bib93; @bib8; @bib26]). The sequelae of MDD comprise several emotional as well as cognitive symptoms, which are considered to merely reflect a bias towards negatively-valenced information processing leading to adverse emotional responsiveness, attention, and dysfunctional executive function ([@bib66; @bib7; @bib21; @bib24; @bib62]). Imaging studies have provided compelling evidence of altered emotion networks in MDD encompassing the amygdala and the anterior cingulate cortex ([@bib22; @bib72; @bib73]), highlighting the superior role of the cortical midline structures in the pathogenesis of MDD and antidepressant treatment response ([@bib54; @bib56; @bib47]). Recently, more attention has been paid to cognitive control mechanisms in patients with concurrent major depressive episodes (MDEs) ([@bib37; @bib79; @bib59; @bib95; @bib27; @bib82; @bib86; @bib91; @bib20; @bib77]) demonstrating increasingly converging evidence of less default mode network (DMN) suppression during performance of attention-demanding tasks ([@bib86; @bib21; @bib5; @bib77]). While the DMN ([@bib31; @bib74]) is physiologically activated at rest and deactivated during goal-directed cognition, insufficient DMN suppression has been repeatedly associated with goal-irrelevant functions such as self-referential thought, introspective processing or rumination ([@bib58; @bib32; @bib5; @bib57; @bib63]). Complementary evidence of dysfunctional DMN activation in MDD has also been detected at rest ([@bib29; @bib87; @bib100; @bib19; @bib101; @bib18; @bib30; @bib52; @bib80; @bib23; @bib38]).

While an abundance of imaging research on cognitive control or functioning was conducted in patients with concurrent major depressive episodes (MDEs), studies dedicated to remitted MDD (rMDD) are relatively sparse and inconclusive ([@bib95; @bib70; @bib84; @bib44; @bib45; @bib65; @bib52; @bib67; @bib88; @bib40; @bib99]). Nonetheless, rMDD is of significant clinical interest since it often represents a euthymic state with increased relapse risk ([@bib10; @bib43]) and, together with information on the number of previous MDEs, guides clinical recommendations for antidepressant maintenance treatment ([@bib6]). Apart from providing complementary evidence to disease concepts of symptomatic MDD, the study of rMDD raises the possibility to elucidate the neurobiological and psychological mechanisms underlying maintenance of remission as well as determinants of relapse ([@bib57]). While the majority of above-mentioned rMDD studies focused on possible alterations in task-positive networks, the involvement of task-negative DMN regions gains increasing attention ([@bib40; @bib52]). Specifically, the extent of DMN suppression, which has been shown to be crucial for goal-directed cognition and to be dysfunctional in symptomatic MDD ([@bib21; @bib32; @bib5; @bib63; @bib50]), has yet to be thoroughly studied in this specific patient group ([@bib57]). Additionally, several limitations present in previously published rMDD studies such as concomitant antidepressant treatment ([@bib95; @bib84; @bib65; @bib52]), moderate sample size ([@bib70; @bib67]), or incomplete remission ([@bib95; @bib84]) make it difficult to draw final conclusions.

Hence, we conducted a cross-sectional functional magnetic resonance imaging (fMRI) study in a large sample of adult fully remitted and drug-free MDD patients as well as adult healthy controls (HC) without any previous psychiatric life-time diagnosis. Additionally, we investigated possible behavioral and neural differences with respect to age of MDD onset, because adolescent-onset MDD contrasts clinically with its adult-onset counterpart with regard to chronicity, severity, vulnerability, and stress-sensitivity ([@bib36; @bib46; @bib96; @bib1; @bib28; @bib102; @bib42; @bib71; @bib85; @bib75]). The main goal of this study was to assess both task-positive ([@bib17]) and task-negative ([@bib5]) differences of neural networks that are engaged or suppressed during working-memory (WM) performance. Based on recent findings demonstrating a relationship between reduced DMN suppression and increased rumination in symptomatic MDD ([@bib32]), we hypothesized to observe similar deficits in full remission, a condition, where maladaptive self-referential processing has been associated with onset of depressive symptoms ([@bib66; @bib61]). Moreover, we expected that adolescent-onset rMDD patients would be more severely affected than those with adult-onset given the more deleterious course of adolescent-onset MDD.

2. Methods and materials {#sec2}
========================

2.1. Participants {#sec2.1}
-----------------

Study volunteers recruited by online advertisements, announcements on bulletin boards or word of mouth were invited to the outpatient clinic of the Department of Psychiatry and Psychotherapy, Medical University of Vienna (MUV), Vienna, Austria, to participate in this cross-sectional fMRI study. Study procedures were approved by the Ethics Committee (EC) of the MUV (EC Number: 11/2008) according to the Declaration of Helsinki ([@bib98]). All participants, who were adult and fully capable to give written informed consent, were considered and financially compensated for their expenditure of time.

After a comprehensive clinical assessment comprising previous history, neurological and medical examinations involving electrocardiography, blood pressure measurement and routine laboratory testing, all subjects underwent a thorough psychiatric examination. Diagnoses were evaluated according to the German version of the Structured Clinical Interview for DSM-IV Axis I disorders (SCID-I) ([@bib97]). Depressive symptoms were assessed by the 21-item version of the Hamilton Rating Scale for Depression (HAM-D) ([@bib33]). Only healthy participants without any previous or concurrent Axis I disorder were enrolled in this study, whereas previous single or multiple MDEs without any other present or previous axis I disorders were mandatory for inclusion of rMDD patients. In order to exclude cases with questionable clinical significance, only patients reporting previous antidepressant treatment (antidepressant medication, psychotherapy, or both) were included. Only rMDD patients who remitted and discontinued any antidepressant treatment at least three months prior to study enrollment were considered. Based on recent recommendations for considering remission and normal levels of functionality ([@bib78]) a total HAM-D score ≤5 was required for all subjects. A complete list of further inclusion- and exclusion criteria is available in the [Supplemental Information](#appsec1){ref-type="sec"}. Consecutively, 78 adult rMDD patients were enrolled in this study. With respect to age of onset, adolescent-onset was defined as ≤19 years and adult-onset as \>19 years ([@bib71]). 42 adult HC chosen from a larger sample were automatically age- and gender-matched for both adult rMDD subgroups comprising 42 adolescent- and 36 adult-onset patients using an optimal full matching procedure ([@bib34]).

2.2. Paradigm {#sec2.2}
-------------

Prior to scanning, subjects received a standardized instruction and computerized training for the classical digit variant of the *n*-back task ([@bib13]) with two complexity conditions. The *n*-back task was designed to engage subjects to constantly update their mental set while minimizing interference from incoming stimuli (digits 1--4). Briefly, subjects had to follow a simple visual instruction ahead of each task block that indicated if they had to recall any number seen two presentations before (two-back; 2B) or if they had to identify the digit currently seen (zero-back; 0B). This WM paradigm consisted of four 2B blocks and four 0B blocks in total, each lasting for 30 s. Fourteen digits were pseudo-randomly presented for 1000 ms and followed by a 1000 ms inter-stimulus-interval at the corners of a trapeze-shaped array within each block. Visual stimuli were displayed using standard software (Presentation 10.3, <http://www.neurobs.com/>) and presented via a back-projection screen by a beamer placed outside the scanner room. Performance data represented as percentage (accuracy) as well as latencies (given in milliseconds) of correct responses were recorded via response buttons of an MRI-compatible response box fixed on the right thigh. Subjects replied with their right hand, using the middle finger for digit 1, the ring finger for digit 2, the index finger for digit 3 and the little finger for digit 4.

2.3. Demographic, clinical and behavioral data analyses {#sec2.3}
-------------------------------------------------------

Demographic and psychometric differences between subgroups (adolescent- and adult-onset rMDD patients, HC) were investigated utilizing a one-way analysis of variance (ANOVA) or a chi-squared contingency table test. The German vocabulary scale "Wortschatztest" (WST) ([@bib83]), an operationalization of verbal intelligence, was assessed to confirm comparable education levels between the investigated subgroups. Additionally, response style questionnaire (RSQ) ([@bib66]) data were available for a subsample of 39 participants (adolescent-onset rMDD patients: *n* = 14, adult-onset rMDD patients: *n* = 9, HC: *n* = 16), and were utilized to study the relationship between the personality trait rumination and imaging results within a post-hoc regression analysis. Clinical differences between the rMDD subgroups were tested by a two-sample t-test or a two-sample Wilcoxon test, where appropriate.

In accordance with previous studies employing the *n*-back task ([@bib79; @bib84]), WM performance represented by accuracy and reaction time (RT) was recorded after stimulus onset for each complexity condition and examined by a repeated-measures ANOVA using one within-subject factor (WM load: two levels) and one between-subject factor (group: three levels). Behavioral analyses including scanner motion parameters were also examined by an ANOVA. Including age and gender in an additional analysis of co-variance (ANCOVA) did not alternate these results. All analyses were performed in R (version 3.1.1, <http://cran-r-project.org/>). The significance threshold was set at p \< 0.05, two tailed.

2.4. Imaging {#sec2.4}
------------

A detailed description of image acquisition and preprocessing is available in the supplemental information. Briefly, fMRI data processing was carried out using AFNI (<http://afni.nimh.nih.gov/afni/>) implemented into an R framework (<http://cran.r-project.org/>) ([@bib11]). Second-level activation analysis was conducted utilizing a mixed-effects meta-analysis approach (3dMEMA), which takes advantage of both beta-coefficients and t-values thereby accounting for between-subject variability and also the precision estimates of individual subject analyses ([@bib16]). Age and gender were modeled as covariates of no interest in all group comparisons. Functional connectivity (FC) analysis was performed for two 4 mm spherical seeds representing maximal task-negative and -positive group differences (anterior-medial prefrontal cortex, amPFC: 5, 46, 12; dorsolateral PFC, dlPFC: −25, 26, 38). Fisher z-transformed correlation maps were used as dependent variable within a general linear model for between group comparisons using age and gender as covariates of no interest. Second-level results have been corrected for multiple comparisons in a whole-brain analysis of regions activated by the task for activation, and within a whole-brain mask for FC analysis using family-wise error (FWE) rates. Proportional variance estimation (s^2^) for regression analysis of behavioral imaging correlates was based on the package 'relaimpo' (relative importance metrics).

3. Results {#sec3}
==========

3.1. Demographics and behavior {#sec3.1}
------------------------------

Demographic, clinical as well as behavioral data of all subjects are displayed in [Table 1](#tbl1){ref-type="table"}. No significant group differences were detected with respect to age (F~(2,\ 117)~ = 1.35, *p* = 0.11), gender (χ^2^~(5)~ = 3.9, *p* = 0.56), years of education (F~(2,\ 117)~ = 0.88, *p* = 0.42), and the WST (F~(2,\ 116)~ = 0.85, *p* = 0.43). HAM-D scores differed significantly between the subgroups (F~(2,\ 117)~ = 6.45, *p* = 0.002) given the large sample size. It is noteworthy, that all subjects were below a conservative HAM-D cut-off ≤5, considered to indicate clinical relevance ([@bib78]).

As expected, there was a significant effect of WM load (2B minus 0B) for both accuracy (F~(1,\ 117)~ = 216.87, *p* \< 0.001) and RT (F~(1,\ 117)~ = 34.14, *p* \< 0.001). No significant main effects were observed for both accuracy (F~(2,\ 117)~ = 2.00, *p* = 0.14) and RT (F~(2,\ 117)~ = 0.52, *p* = 0.59) between all three investigated groups. No significant interaction effects for group and WM load were detected for either accuracy (F~(2,\ 117)~ = 2.41, *p* = 0.094) or RT (F~(2,\ 117)~ = 1.22, *p* = 0.298). Also here, although all subjects showed adequate cognitive performance (0B accuracy \> 80%), a separate condition analysis revealed subtle but significant subgroup differences for 0B RT (F~(2,\ 117)~ = 3.37, *p* = 0.038) given the large sample size.

With respect to scanner motion, we observed rather low maximum translation parameters (mean 0.46 mm, SD = 0.28 mm) with strongest movement of 1.32 mm. Furthermore, we did not observe any significant difference of maximal displacement between all three groups (F~(2,\ 117)~ = 1.86, *p* = 0.16).

3.2. Clinical data of rMDD patients {#sec3.2}
-----------------------------------

Clinical data of rMDD patients are displayed in [Table S1](#appsec1){ref-type="sec"}. Adolescent-onset rMDD patients exhibited more previous MDEs (*p* = 0.001), a higher cumulative number of months of MDEs (*p* = 0.009), a longer duration of illness (t~(76)~ = 4.83, *p* \< 0.0001), a longer duration of remission (*p* = 0.036), and a longer time-span since termination of psychotherapy (*p* = 0.006) than adult-onset rMDD patients. No significant differences were found for HAM-D scores (t~(76)~ = −0.96, *p* = 0.34), cumulative number of months of antidepressant medication (*p* = 0.37), cumulative number of psychotherapy units (*p* = 0.62), and duration of the last MDE in months (*p* = 0.99) between the rMDD subgroups.

3.3. Task activation patterns within the groups {#sec3.3}
-----------------------------------------------

To test if the employed paradigm recruited both, the task-positive WM network (WMN) as well as the task-negative DMN, in our study, we performed a within-group comparison for WM load (2B minus 0B). In all three groups, significantly increased activation was detected in the dlPFC, the ventrolateral PFC (vlPFC) as well as the inferior parietal lobe ([Table 2](#tbl2){ref-type="table"}, [Fig. S1](#appsec1){ref-type="sec"}). Concurrently, significant load-dependent deactivation was found in the amPFC, posterior cingulate cortex (PCC), as well as in the adjacent frontal-, temporal-, and parahippocampal gyrus ([Table 2](#tbl2){ref-type="table"}, [Fig. S1](#appsec1){ref-type="sec"}). While the overall peak of activation was clearly found in the dlPFC, maximal deactivation was located in the amPFC in all three groups ([Table 2](#tbl2){ref-type="table"}, [Fig. S1](#appsec1){ref-type="sec"}).

3.4. Regional activation differences between rMDD patients and HC {#sec3.4}
-----------------------------------------------------------------

In comparison to HC, rMDD patients showed a significantly diminished deactivation of DMN regions with punctum maximum in the amPFC, while no significant group differences were found in typical WM areas ([Fig. 1](#fig1){ref-type="fig"}A and C, [Fig. S2A](#appsec1){ref-type="sec"}; [Table 3](#tbl3){ref-type="table"}). Significant effects were even more pronounced, when comparing HC to adolescent-onset rMDD patients, where the latter exhibited significantly reduced DMN deactivation, which was most prominent in the amPFC, the PCC, and the temporal lobe ([Fig. 1](#fig1){ref-type="fig"}B and C, [Fig. S2B](#appsec1){ref-type="sec"}; [Table 3](#tbl3){ref-type="table"}). Interestingly, adolescent-onset rMDD patients differed similarly from adult-onset rMDD patients, though not reaching significance ([Fig. 1](#fig1){ref-type="fig"}C, [Fig. S2](#appsec1){ref-type="sec"}D; [Table 3](#tbl3){ref-type="table"}). In contrast, activation patterns of adult-onset rMDD patients did not significantly differ from HC ([Fig. 1](#fig1){ref-type="fig"}C, [Fig. S2C](#appsec1){ref-type="sec"}; [Table 3](#tbl3){ref-type="table"}).

3.5. Brain systems differences between rMDD patients and HC {#sec3.5}
-----------------------------------------------------------

To investigate the degree of coupling between the DMN and the WMN, we calculated FC for regions with maximal task-negative (amPFC) and -positive (dlPFC) group differences. Analogous to activation results, FC analyses revealed significant differences between adolescent-onset rMDD patients and HC. Compared to HC, adolescent-onset rMDD patients exhibited significantly reduced coupling of the amPFC with most brain regions ([Fig. 2](#fig2){ref-type="fig"}A and D, [Fig. S3](#appsec1){ref-type="sec"}; [Table 4](#tbl4){ref-type="table"}) except the dlPFC ([Fig. 2](#fig2){ref-type="fig"}A and C, [Fig. S3](#appsec1){ref-type="sec"}; [Table 4](#tbl4){ref-type="table"}). Inversely, the dlPFC as seed region mirrored this result demonstrating increased FC with the amPFC and decreased FC between the dlPFC and the remaining brain regions ([Fig. S4](#appsec1){ref-type="sec"}; [Table 4](#tbl4){ref-type="table"}). In contrast, adult-onset rMDD patients exhibited a qualitatively similar, but less-pronounced coupling pattern for both seed regions, which did not significantly differ from HC or adolescent-onset rMDD patients ([Fig. 2](#fig2){ref-type="fig"}C and D, [Fig. S3E and F](#appsec1){ref-type="sec"}, [Fig. S4E and F](#appsec1){ref-type="sec"}).

3.6. Post hoc behavioral analysis {#sec3.6}
---------------------------------

To investigate the relationship between behavioral and imaging data, we performed a *post hoc* linear regression analysis of accuracy and neural activation on a regional as well as brain systems level while controlling for age and gender. We correlated the strongest group difference for deactivation (amPFC) and FC (amPFC was used as seed region), and observed a significant negative relationship between 2B accuracy and amPFC-dlPFC coupling (s^2^ = 8.1%; t~(116)~ = −3.22, *p* = 0.0016, [Fig. 2](#fig2){ref-type="fig"}B). In addition, we found a trend-wise significant positive correlation of 0B accuracy with amPFC-medial frontal gyrus (mFG) coupling (s^2^ = 2.9%; t~(116)~ = 1.93, *p* = 0.0557) as well as a negative correlation with the amPFC activation (s^2^ = 2.3%; t~(116)~ = −1.7, *p* = 0.0896).

3.7. Post hoc response style analysis {#sec3.7}
-------------------------------------

A *post-hoc* regression analysis of RSQ data and imaging results indicated that reduced DMN deactivation is significantly associated with an increased ruminative response style (s^2^ = 14.3%, t~(35)~ = 2.39, *p* = 0.023; [Fig. 3](#fig3){ref-type="fig"}A). Moreover, rumination differed significantly between subgroups (F~(2,\ 35)~ = 6.26, *p* = 0.0047) with maximal rumination values in adolescent-onset rMDD patients and lowest in HC, while adult-onset rMDD patients showed intermediate scores ([Fig. 3](#fig3){ref-type="fig"}B). Similar to previous analyses, age and gender were modeled as covariates of no interest.

4. Discussion {#sec4}
=============

The main goal of the present study was to investigate putative functional alterations of neural networks that are engaged or suppressed during WM performance in a large sample of adult drug-free rMDD patients and HC. Briefly, in comparison to HC, rMDD patients showed a significantly diminished deactivation of DMN nodes, which are known to be suppressed during externally directed WM performance ([@bib5]). Moreover, the present study revealed that such reduced suppression of the DMN was significant only in adolescent-onset rMDD patients, putatively reflecting the more chronic course of early-onset MDD from a neurobiological perspective. On a brain systems level, adolescent-onset rMDD patients showed increased amPFC-dlPFC coupling, while all other connections within the WMN and DMN regions showed an inverse directionality. This tight coupling might underlie decreased reciprocal inhibition between the anterior parts of these antagonistic networks. Moreover, the fact that the strongest DMN disinhibition was detected in the amPFC underlines the superior role of this cortical midline structure in the dynamic interplay between several large-scale neural circuitries, encompassing the fronto-parietal central executive network, cingulo-opercular salience network (SN), and the medial prefrontal-medial parietal DMN, which has been shown to be dysfunctional in depression ([@bib51; @bib52; @bib55]) and other major neuropsychiatric disorders ([@bib60; @bib15; @bib92]). In detail, the present findings are in line with the idea that a dysfunctional amPFC interferes with bottom-up processes during WM-related computations in MDD patients. As a consequence, top-down control mechanisms are likely initiated to down-regulate the DMN system, but fail to completely suppress its activity ([@bib21; @bib5]).

The key finding of this study is the reduced DMN suppression in MDD patients existing even after full recovery, which mirrors findings in symptomatic- ([@bib79; @bib29; @bib86; @bib87; @bib21; @bib100; @bib5; @bib19; @bib101; @bib18; @bib30; @bib52; @bib80; @bib23; @bib77]) and euthymic- ([@bib95; @bib84; @bib88]) MDD patients. This reduction of DMN suppression, which is accompanied by increased ruminative response style in our study, might therefore be interpreted as increased self-referential processing as well as insufficient inhibition of conflicting computations in line with previous literature ([@bib58; @bib32; @bib5; @bib57; @bib63]). It is noteworthy that rumination has been found to be mediated by midline cortical structures of the DMN ([@bib68; @bib32; @bib69; @bib63]) and to predict MDD onset, severity ([@bib54; @bib69]), and duration ([@bib66; @bib61]). Hence, we are tempted to speculate that the dysfunctional DMN suppression present in non-symptomatic MDD patients could also render the biological signature of increased relapse likelihood. This assumption is further supported by significantly pronounced DMN suppression deficits in adolescent-onset rMDD patients, who are prone to a more severe and chronic course compared to MDD patients with later onset, as repeatedly suggested in previous studies ([@bib36; @bib46; @bib96; @bib1; @bib102; @bib42; @bib71; @bib85; @bib75]).

Our data are further underlined by a recently published imaging study of remitted depressed young adults demonstrating that hyperconnectivities of the DMN and the SN with cognitive control networks are related to rumination and sustained attention ([@bib40]). Similar neural alterations of the medial prefrontal cortex (mPFC) have been observed in another recent study in rMDD patients reporting an association between dysfunctional deactivation of the dorsomedial PFC and impaired autobiographical memory ([@bib99]). Our results resembling the critical role of the mPFC in neural alterations being found in symptomatic-as well as euthymic MDD patients ([@bib99; @bib40]) hint at the possibility that neural dysfunction may persist even after full recovery of MDD. The mPFC is known to represent a critical neural hub that is involved in self-referential processing such as autobiographical memory, rumination, and cognitive control. It is noteworthy that one important function of the mPFC is to integrate contextual information of autobiographical memory in order to imagine the future ([@bib81; @bib25]). The context-dependent autobiographical memory has been shown to be negatively-biased and less specific in symptomatic- and to some degree also in remitted MDD patients ([@bib25; @bib49]), and is therefore thought to reflect a specific cognitive style, which might predict antidepressant treatment response and depression relapse ([@bib66; @bib54; @bib69; @bib61; @bib4]). Together with the known stress-sensitivity of the mPFC, conditions of uncontrollable stress paralleled by an exacerbation of helplessness and rumination could therefore be responsible for depression relapse ([@bib66; @bib2]).

While there is little doubt today that functioning of DMN-related brain regions is affected in MDD and other psychiatric disorders, the role of the DMN and the regional specialization of anterior and posterior parts of the human medial cortex has been increasingly investigated in the context of various mental processes ([@bib3; @bib9; @bib4; @bib12; @bib50]). Accordingly, neural alterations linked to symptoms like rumination as demonstrated for the mPFC and the DMN clearly show that underlying neural signatures are not limited to DSM-defined boundaries. Hence, such neural changes observed in symptomatic as well as euthymic MDD are thought to reflect disease-related changes of neural systems that might be of diagnostic value in future neurobiology-based diagnostic systems ([@bib64; @bib39; @bib41]).

In contrast to the marked neural activation differences between rMDD patients and HC, the main effects on WM performance were statistically indistinguishable between the groups, which is in line with the majority of previous reports ([@bib95; @bib84; @bib44; @bib45; @bib67]). However, the non-isomorphism between brain function and behavior present in this study could further be related to the chosen maximal WM-load of the behavioral paradigm (2B), which might change, when WM-load increases (e.g. 3B, 4B) or stress-related environmental distractors, requiring a more rigorous control of the DMN, are involved. Our *post hoc* analysis of the relation between behavioral and imaging data revealed a significant negative correlation between amPFC-dlPFC coupling and 2B accuracy. This finding indicates that less accuracy is accompanied by DMN-WMN hyperconnectivity, which might reflect the increased relapse risk of rMDD patients ([@bib40]). While our results as well as limited evidence available from recent studies ([@bib40; @bib99]) hint at the importance of DMN-WMN interplay with respect to depression relapse prediction, future longitudinal studies are clearly needed in order to validate the assumption that a dysfunctional DMN is causally related to increased relapse likelihood in MDD patients.

Despite the intriguing neural alterations observed in this large study of fully-recovered drug-free rMDD patients, some limitations may apply. To address the biological heterogeneity of MDD, we decided to sub-group our patient sample according to disease onset, which was driven by encouraging reports on distinct biological signatures of adolescent MDD patients ([@bib71]), well-known clinical differences between adolescent- and adult-onset MDD patients ([@bib102]), and the ease and precision of assessment. While competing sub-classifications such as typical/atypical depression, single/multiple episode MDD as well as others ([@bib35; @bib48; @bib89; @bib90; @bib76; @bib94]) exist, their biological significance is still under debate and has not fully been addressed yet ([@bib39; @bib14]). Thus, we are confident that our choice to subgroup patients according to disease onset is appropriate for this study type. Notably, the present cross-sectional study targets exclusively the remitted phase of MDD, and therefore does not allow a direct comparison to symptomatic MDD. Hence, all inferences being made with respect to symptomatic MDD are purely literature-based. However, we are confident that our conclusions are not too far-fetched given the multitude of imaging literature on symptomatic MDD.

Summarizing, this study demonstrates that DMN alterations persist even after full recovery of MDEs. Observed neural activation patterns were related to rumination, which is a well-established indicator of MDD severity ([@bib32]). Brain systems level analyses mirrored the aberrant DMN suppression in rMDD patients and underlined the specific role of the amPFC as mediator of these effects ([@bib51; @bib15; @bib52]). In contrast to adult-onset rMDD patients, adolescent-onset rMDD patients exhibited significant local as well as systems level findings, which might reflect the more detrimental clinical course of this diagnostic subgroup. In conclusion, this study demonstrating reduced DMN suppression in rMDD patients encourages the investigation of DMN suppression measures as putative relapse predictor in future clinical trials, which might eventually lead to important implications for antidepressant maintenance treatment.
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The following is the supplementary data related to this article:
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![Activation Differences between rMDD Patients (*n* = 78) and HC (*n* = 42). Significantly decreased DMN deactivation (red) in rMDD patients compared to HC (A, C). Maximal effects are being found in the amPFC. Task activation (yellow) and deactivation (cyan) is presented as underlay of group comparison results in order to outline the DMN. Adolescent-onset rMDD patients exhibit significant and even more pronounced DMN deactivation decreases with punctum maximum in the amPFC and the PCC compared to HC (B, C). Plot (C) summarizes the significance of FWE corrected group comparisons for the amPFC and further visualizes the intermediate position of adult-onset rMDD patients compared to adolescent-onset MDD patients and HC. Abbreviations: \*\*, highly significant (*p* \< 0.01); \*, significant (*p* \< 0.05); 95% CI, 95% confidence interval; FWE, family-wise error rate; rMDD, remitted Major Depressive Disorder; HC, healthy controls; DMN, default-mode network; amPFC, anterior-medial prefrontal cortex; PCC, posterior cingulate cortex. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr1){#fig1}

![Differences in functional connectivity between adolescent-onset rMDD patients (*n* = 42) and HC (*n* = 42). The amPFC has been used as seed region (5, 46, 1) for FC analyses based on working memory paradigm data after removing task-based co-activation. The figure displays significantly increased (red) coupling of the amPFC with the dlPFC (A, C) and significantly decreased coupling (blue) with the mFG (A, D) in adolescent-onset rMDD patients compared to HC. Task activation (yellow) and deactivation (cyan) is presented as underlay of group comparison results in order to outline the DMN (A). A significant negative correlation was detected between 2B accuracy and amPFC-dlPFC coupling (B). Plots (C, D) summarize the significance of FWE corrected group comparisons for amPFC-dlPFC as well as amPFC-mFG FC and further visualize the intermediate position of adult-onset rMDD patients compared to adolescent-onset rMDD patients and HC. Abbreviations: \*\*, highly significant (*p* \< 0.01); \*, significant (*p* \< 0.05); 95% CI, 95% confidence interval; FWE, family-wise error rate; rMDD, remitted Major Depressive Disorder; HC, healthy controls; FC, functional connectivity; amPFC, anterior-medial prefrontal cortex; dlPFC, dorsolateral prefrontal cortex; mFG, medial frontal gyrus; DMN, default-mode network; 2B, two-back. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr2){#fig2}

![Post hoc response style analysis. A reduction of amPFC deactivation is significantly associated with RSQ score increases (A) in all study participants with available RSQ data (*n* = 39). Both rMDD subgroups show significantly higher RSQ scores than HC with more pronounced effects in adolescent-onset rMDD patients (B). Studied subgroups are depicted by symbols: adolescent-onset (square) and adult-onset rMDD patients (triangle), HC (circle). Abbreviations: \*\*, highly significant (*p* \< 0.01); \*, significant (*p* \< 0.05); s^2^, estimated proportion of explained variance; rMDD, remitted Major Depressive Disorder; HC, healthy controls; amPFC, anterior-medial prefrontal cortex; RSQ, Response Style Questionnaire.](gr3){#fig3}

###### 

Demographic, clinical, and behavioral characteristics (*n* = 120).

                     rMDD Patients     HC (*n* = 42)     F/χ^2^            *p*     
  ------------------ ----------------- ----------------- ----------------- ------- -----------
  Age, y             26.0 (4.8)        27.6 (5.7)        25.3 (4.2)        1.345   0.110
  Females            60%               53%               60%               3.9     0.560
  Education, y       12.5 (1.1)        12.7 (0.7)        12.7 (0.8)        0.878   0.418
  WST                33.7 (2.7)        33.1 (2.3)        33.9 (3.2)        0.853   0.429
  HAM-D              1.6 (1.5)         1.9 (1.6)         0.7 (1.3)         6.449   0.002\*\*
  Accuracy 0B        0.98 (0.04)       0.98 (0.04)       0.98 (0.03)       0.239   0.788
  Accuracy 2B        0.73 (0.18)       0.76 (0.16)       0.81 (0.15)       2.213   0.114
  Reaction time 0B   604.64 (106.05)   638.70 (135.43)   561.93 (129.22)   3.367   0.038\*
  Reaction time 2B   495.84 (204.02)   476.34 (213.66)   476.03 (259.82)   0.150   0.861

Continuous variables are presented as mean (standard deviation). Abbreviations: \*\*, highly significant (*p* \< 0.01); \*, significant (*p* \< 0.05); rMDD, remitted Major Depressive Disorder; HC, healthy controls; WST, Wortschatztest; HAM-D, Hamilton Depression Rating Scale; MDE, Major Depressive Episode; y, years; 0B, zero-back; 2B, two-back.

###### 

Activation main effects of the *n*-back task in rMDD patients and HC (*n* = 120).

  Region         BA           Cluster (mm^3^)   z        *p*           x     y     z
  -------------- ------------ ----------------- -------- ------------- ----- ----- -----
  dlPFC          9, 45, 46    71,650            13.00    \<0.001\*\*   1     9     52
  IPL            40           36,846            12.70    \<0.001\*\*   38    −46   41
  amPFC          10           18,318            −11.96   \<0.001\*\*   −6    48    12
  PCC            29, 30       6417              −12.26   \<0.001\*\*   −6    −52   21
  MidSupITempG   21           1957              −10.53   \<0.001\*\*   −58   −8    −8
  Insula         13           1591              −10.60   \<0.001\*\*   36    −19   21
  vlPFC          24, 32, 33   1434              10.76    \<0.001\*\*   −16   −2    23
  Insula         13           837               −10.36   \<0.001\*\*   −34   −19   21
  PHG            28, 35       523               −9.55    \<0.001\*\*   −25   −22   −12
  IMidFG         11, 47       241               −9.32    \<0.001\*\*   −38   31    −8

Positive z-scores indicate an increase and negative z-scores a decrease of activation; x, y, z are coordinates in Talairach space (LPI). Abbreviations: \*\*, highly significant (FWE corrected *p* \< 0.01); \*, significant (FWE corrected *p* \< 0.05); rMDD, remitted Major Depressive Disorder; HC, healthy controls; BA, Brodmann Area; FWE, family-wise error rate; dlPFC, dorsolateral prefrontal cortex; IPL, inferior parietal lobe; amPFC, anterior-medial prefrontal cortex; PCC, posterior cingulate cortex; MidSupITempG, middle, superior and inferior temporal gyrus; vlPFC, ventrolateral prefrontal cortex; PHG, parahippocampal gyrus; IMidFG, inferior and middle frontal gyrus.

###### 

Activation differences between rMDD patients (*n* = 78) and HC (*n* = 42).

  Region                                                        BA      Cluster (mm^3^)   z       *p*           x     y     z
  ------------------------------------------------------------- ------- ----------------- ------- ------------- ----- ----- ----
  rMDD patients (*n* = 78) vs. HC (*n* = 42)                                                                                
   PCG                                                          3, 40   1760              −3.87   \<0.001\*\*   −38   −32   58
   amPFC                                                        10      1571              −3.61   \<0.001\*     8     48    12
   STG                                                          42      1184              −3.52   \<0.001\*     58    −11   10
   PCC                                                          24      1027              −3.44   \<0.001^+^    3     22    32
  Adolescent-onset rMDD patients (*n* = 42) vs. HC (*n* = 42)                                                               
   amPFC                                                        10      6976              −4.33   \<0.001\*\*   5     46    12
   PCC                                                          24      5730              −4.20   \<0.001\*\*   5     −17   36
   STG                                                          42      1561              −3.70   \<0.001\*     58    −13   10
   STG                                                          43      1100              −3.45   \<0.001^+^    −51   −6    14
   STG                                                          3, 40   1016              −3.43   \<0.001^+^    −38   −32   58

Positive/negative z-scores represent increased/decreased deactivation of rMDD patients versus HC (two-back vs. zero-back); x, y, z are coordinates in Talairach space (LPI). Abbreviations: \*\*, highly significant (FWE corrected *p* \< 0.01); \*, significant (FWE corrected *p* \< 0.05); ^+^, trend-wise significant (FWE corrected + *p* \< 0.10); BA, Brodmann area; rMDD, remitted Major Depressive Disorder; HC, healthy controls; FWE, family-wise error rate; PCG, postcentral gyrus; amPFC, anterior-medial prefrontal cortex; PCC, posterior cingulate cortex; STG, superior temporal gyrus.

###### 

Differences in functional connectivity between adolescent-onset rMDD patients (*n* = 42) and HC (*n* = 42).

  Region      Seed    BA     Cluster (mm^3^)   z       *p*           x     y     z
  ----------- ------- ------ ----------------- ------- ------------- ----- ----- ----
  MedFG       amPFC   10     1687              −3.52   \<0.001\*\*   3     59    17
  dlPFC       amPFC   9, 8   1446              3.52    \<0.001\*     −27   33    43
  Precuneus   dlPFC   31     4745              −4.22   \<0.001\*\*   25    −41   36
  SupMidFG    dlPFC   8, 9   2409              −4.44   \<0.001\*\*   38    35    36
  amPFC       dlPFC   10     2388              3.94    \<0.001\*\*   −10   46    1
  MidFG       dlPFC   6      2273              −4.23   \<0.001\*\*   27    3     41
  SupMidFG    dlPFC   10     1257              −3.44   \<0.001\*     −27   48    17
  SupMidFG    dlPFC   6      1246              −3.95   \<0.001\*     −18   −7    65

Positive/negative z-scores represent increased/decreased functional connectivity. Seeds are in the amPFC (5, 46, 12) and the dlPFC (−25, 26, 38). Significance is indicated by \* (FWE corrected \*\**p* \< 0.01, \**p* \< 0.05); x, y, z are coordinates in Talairach space (LPI). Abbreviations: BA, Brodmann Area; rMDD, remitted Major Depressive Disorder; HC, healthy controls; dlPFC, dorsolateral prefrontal cortex; amPFC, anterior-medial prefrontal cortex; SupMidFG, superior and middle frontal gyrus; MidFG, middle frontal gyrus; MedFG, medial frontal gyrus.

[^1]: These authors contributed equally to this work.
